Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1223-49.
US Department of Health and Human Services. The Health Consequences of Smoking–50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
Caliri AW, Tommasi S, Besaratinia A. Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer. Mutat Res Rev Mutation Res. 2021; 787: epub ahead of print 11 January 2021; https://doi.org/10.1016/j.mrrev.2021.108365.
DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139:136–53.
Reuther WJ, Brennan PA. Is nicotine still the bad guy? Summary of the effects of smoking on patients with head and neck cancer in the postoperative period and the uses of nicotine replacement therapy in these patients. Br J Oral Maxillofac Surg. 2014;52:102–105.
Sørensen LT. Wound healing and infection in surgery: the clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012;147:373–83.
Brody AL, Gehlbach D, Garcia LY, Enoki R, Hoh C, Vera D, et al. Effect of overnight smoking abstinence on a marker for microglial activation: A [11C]DAA1106 positron emission tomography study. Psychopharmacology. 2018;35:3525–34.
Brody AL, Hubert R, Enoki R, Garcia LY, Mamoun MS, Okita K, et al. Effect of cigarette smoking on a marker for neuroinflammation: A [11C]DAA1106 positron emission tomography study. Neuropsychopharmacology. 2017;42:1630–1639.
Trapani A, Palazzo C, de Candia M, Lasorsa FM, Trapani G. Targeting of the translocator protein 18 kDa (TSPO): a valuable approach for nuclear and optical imaging of activated microglia. Bioconjugate Chem. 2013;24:1415–28.
Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, Hammers A, et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med. 2007;48:158–67.
Kim SW, Wiers CE, Tyler R, Shokri-Kojori E, Jang YJ, Zehra A, et al. Influence of alcoholism and cholesterol on TSPO binding in brain: PET [11C]PBR28 studies in humans and rodents. Neuropsychopharmacology. 2018;43:1832–1839.
Albrecht DS, Granziera C, Hooker JM, Loggia ML. In vivo imaging of human neuroinflammation. ACS Chem Neurosci. 2016;7:470–83.
Chang L, Munsaka SM, Kraft-Terry S, Ernst T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharm. 2013;8:576–93.
Mader I, Rauer S, Gall P, Klose U. 1H MR spectroscopy of inflammation, infection and ischemia of the brain. Eur J Radio. 2008;67:250–257.
Quarantelli M. MRI/MRS in neuroinflammation: methodology and applications. Clin Transl Imaging. 2015;3:475–89.
Fedota JR, Stein EA. Resting-state functional connectivity and nicotine addiction: prospects for biomarker development. Ann NY Acad Sci. 2015;1349:64–82.
Hong LE, Hodgkinson CA, Yang Y, Sampath H, Ross TJ, Buchholz B, et al. A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. PNAS USA. 2010;107:13509–14.
Janes AC, Betts J, Jensen JE, Lukas SE. Dorsal anterior cingulate glutamate is associated with engagement of the default mode network during exposure to smoking cues. Drug Alcohol Depend. 2016;167:75–81.
Zhao L-Y, Tian J, Wang W, Qin W, Shi J, Li Q et al. The role of dorsal anterior cingulate cortex in the regulation of craving by reappraisal in smokers. PLoS One. 2012; 7; epub ahead of print 22 Aug 2012: https://doi.org/10.1371/journal.pone.0043598.
Kunas SL, Bermpohl F, Plank IS, Ströhle A, Stuke H. Aversive drug cues reduce cigarette craving and increase prefrontal cortex activation during processing of cigarette cues in quitting motivated smokers. Addiction Biol. 2022;27:e13091.
Ghahremani DG, Pochon J-B, Perez Diaz M, Tyndale RF, Dean AC, London ED. Functional connectivity of the anterior insula during withdrawal from cigarette smoking. Neuropsychopharmacology. 2021;46:2083–2089.
Mennecke A, Gossler A, Hammen T, Dörfler A, Stadlbauer A, Rösch J, et al. Physiological effects of cigarette smoking in the limbic system revealed by 3 Tesla magnetic resonance spectroscopy. J Neural Transm. 2014;121:1211–1219.
Schulte M, Goudriaan A, Kaag A, Kooi D, Van Den Brink W, Wiers R, et al. The effect of N-acetylcysteine on brain glutamate and gamma-aminobutyric acid concentrations and on smoking cessation: a randomized, double-blind, placebo-controlled trial. J Psychopharmacol. 2017;31:1377–1379.
Abulseoud OA, Ross TJ, Nam HW, Caparelli EC, Tennekoon M, Schleyer B, et al. Short-term nicotine deprivation alters dorsal anterior cingulate glutamate concentration and concomitant cingulate-cortical functional connectivity. Neuropsychopharmacology. 2020;45:1920–30.
Tanner J-A, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, et al. Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: Implications for clinical implementation measuring nicotine metabolite ratio by different methods. Cancer Epidemiol Biomark Prev. 2015;24:1239–46.
Hergueta T, Weiller E. Evaluating depressive symptoms in hypomanic and manic episodes using a structured diagnostic tool: validation of a new Mini International Neuropsychiatric Interview (MINI) module for the DSM-5 ‘With Mixed Features’ specifier. Int J Bipolar Disord. 2013;1:1–10.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119–27.
Brown RA, Lejuez C, Kahler CW, Strong DR. Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol. 2002;111:180–185.
Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology. 1976;50:35–39.
O’Neill J, Lai TM, Sheen C, Salgari GC, Ly R, Armstrong C, et al. Cingulate and thalamic metabolites in obsessive-compulsive disorder. Psychiatry Res Neuroimaging. 2016;254:34–40.
Alger J, Stanovich J, Lai J, Armstrong C, Feusner J, Levitt J, et al. Performance validation of a new software package for analysis of 1H-MRS. ISMRM Workshop on MR Spectroscopy: From Current Best Practice to Latest Frontiers. Lake Constance, Germany, Aug 14-17, 2016 (Abstract). https://www.ismrm.org/workshops/Spectroscopy16/.
Markwardt CB. Non-linear least squares fitting in IDL with MPFIT. Proc. arXiv. 2009:0902.2850 ADASS XVIII, ASP Conf. Ser., Vol. 411, eds. D. Bohlender, P. Dowler & D. Durand, 2009, p. 251 (Abstract).
Soher BJ, Young K, Govindaraju V, Maudsley AA. Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med. 1998;40:822–31.
Young K, Govindaraju V, Soher BJ, Maudsley AA. Automated spectral analysis I: formation of a priori information by spectral simulation. Magn Reson Med. 1998;40:812–815.
Frost J. Hypothesis Testing: an intuitive guide for making data driven decisions. Statistics by Jim Publishing, State College, PA, 2020.
Faulkner P, Petersen N, Ghahremani DG, Cox CM, Tyndale RF, Hellemann GS, et al. Sex differences in tobacco withdrawal and responses to smoking reduced-nicotine cigarettes in young smokers. Psychopharmacology. 2018;235:193–202.
Garey L, Peraza N, Smit T, Mayorga NA, Neighbors C, Raines AM, et al. Sex differences in smoking constructs and abstinence: the explanatory role of smoking outcome expectancies. Psychol Addict Behav. 2018;32:660.
McKee SA, Smith PH, Kaufman M, Mazure CM, Weinberger AH. Sex differences in varenicline efficacy for smoking cessation: a meta-analysis. Nicotine Tob Res. 2016;18:1002–11.
Perez Diaz M, Pochon JB, Ghahremani DG, Dean AC, Faulkner P, Petersen N, et al. Sex differences in the association of cigarette craving with insula structure. Int J Neuropsychopharmacol. 2021;24:624–33.
Petersen N, London ED. Addiction and dopamine: Sex differences and insights from studies of smoking. Curr Opin Behav Sci. 2018;23:150–159.
Hädel S, Wirth C, Rapp M, Gallinat J, Schubert F. Effects of age and sex on the concentrations of glutamate and glutamine in the human brain. J Magn Reson Imaging. 2013;38:1480–1487.
Sailasuta N, Ernst T, Chang L. Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging. 2008;26:667–75.
Wickens MM, Bangasser DA, Briand LA. Sex differences in psychiatric disease: a focus on the glutamate system. Front Mol Neurosci. 2018;11:197.
Faulkner P, Lucini Paioni S, Kozhuharova P, Orlov N, Lythgoe DJ, Daniju Y, et al. Daily and intermittent smoking are associated with low prefrontal volume and low concentrations of prefrontal glutamate, creatine, myo-inositol, and N-acetylaspartate. Addict Biol. 2021; 26: epub ahead of print 3 December 2020; https://doi.org/10.1111/adb.12986.
Hawkins BT, Abbruscato TJ, Egleton RD, Brown RC, Huber JD, Campos CR, et al. Nicotine increases in vivo blood–brain barrier permeability and alters cerebral microvascular tight junction protein distribution. Brain Res. 2004;1027:48–58.
Fan ZK, Cao Y, Lv G, Wang YS, Guo ZP. The effect of cigarette smoke exposure on spinal cord injury in rats. J Neurotrauma. 2013;30:473–479.
Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem. 2004;89:337–43.
Noda M, Kobayashi AI. Nicotine inhibits activation of microglial proton currents via interactions with α7 acetylcholine receptors. J Physiol Sci. 2017;67:235–45.
Suzuki T, Hide I, Matsubara A, Hama C, Harada K, Miyano K, et al. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res. 2006;83:1461–70.
Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: Cellular and molecular mechanisms. J Dent Res. 2012;91:142–149.
Alrouji M, Manouchehrinia A, Gran B, Constantinescu CS. Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis. J Neuroimmunol. 2019;329:24–34.
Rael LT, Thomas GW, Bar-Or R, Craun ML, Bar-Or D. An anti-inflammatory role for N-acetyl aspartate in stimulated human astroglial cells. Biochem Biophys Res Comm. 2004;319:847–53.
Aryal SP, Fu X, Sandin JN, Neupane KR, Lakes JE, Grady ME, et al. Nicotine induces morphological and functional changes in astrocytes via nicotinic receptor activity. Glia. 2021;69:2037–53.
Lim DK, Kim HS. Opposite modulation of glutamate uptake by nicotine in cultured astrocytes with/without cAMP treatment. Eur J Pharm. 2003;476:179–84.
Namba MD, Kupchik YM, Spencer SM, Garcia‐Keller C, Goenaga JG, Powell GL et al. Accumbens neuroimmune signaling and dysregulation of astrocytic glutamate transport underlie conditioned nicotine‐seeking behavior. Addict Biol 2020; 25: epub ahead of print 22 July 2019; https://doi.org/10.1111/adb.12797.
Maddock RJ, Casazza GA, Fernandez DH, Maddock MI. Acute modulation of cortical glutamate and GABA content by physical activity. J Neurosci. 2016;36:2449–57.
Kauppinen RA, Pirttilä TR, Auriola SO, Williams SR. Compartmentation of cerebral glutamate in situ as detected by 1H/13C n.m.r. Biochem J. 1994;298:121–127.
Waagepetersen HS, Sonnewald U, Schousboe A. Glutamine, glutamate, and GABA: metabolic aspects. In: Lajtha A, Oja S, Schousboe A, Saransaari P (eds). Handbook of neurochemistry and molecular neurobiology: amino acids and peptides in the nervous system. Springer: New York, 2007, pp 1–21.
Bovée WM. Quantification of glutamate, glutamine, and other metabolites in in vivo proton NMR spectroscopy. NMR Biomed. 1991;4:81–84.
de Graaf AA, Deutz NE, Bosman DK, Chamuleau RA, de Haan JG, Bovee WM. The use of in vivo proton NMR to study the effects of hyperammonemia in the rat cerebral cortex. NMR Biomed. 1991;4:31–37.
Kauppinen RA, Willaims SR. Nondestructive detection of glutamate by 1H nuclear magnetic resonance spectroscopy in cortical brain slices from the guinea pig: evidence for changes in detectability during severe anoxic insults. J Neurochem. 1991;57:1136–44.
Pirttilä TR, Hakumäki JM, Kauppinen RA. 1H nuclear magnetic resonance spectroscopy study of cerebral glutamate in an ex vivo brain preparation of guinea pig. J Neurochem. 1993;60:1274–82.
Grodin EN, Nieto SJ, Meredith LR, Burnette E, O’Neill J, Alger J et al. Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: a randomized clinical trial. Addict Biol. 2022; 27: epub ahead of print e13182. https://doi.org/10.1111/adb.13182.
Donahue EK, Bui V, Foreman RP, Duran JJ, Venkadesh S, Choupan J, et al. Magnetic resonance spectroscopy shows associations between neurometabolite levels and perivascular space volume in Parkinson’s disease: a pilot and feasibility study. Neuroreport. 2022;33:291–296.
Bates TE, Strangwald M, Keelan J, Davey GP, Munro PM, Clarke JB. Inhibition of N-acetylaspartate production: Implications for 1H MRS studies in vivo. Neuroreport. 1996;7:1397–1400.
Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: Evidence for myelin-associated aspartoacylase. J Neurochem. 2001;78:736–45.
Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev. 1989;13:23–31.
Bennett MR, Balcar VJ. Forty years of amino acid transmission in the brain. Neurochem Int. 1999;35:269–80.
Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. PNAS USA. 1998;95:316–21.
Rae CD. A Guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res. 2014;39:1–36.
Oliveira MS, Furian AF, Fighera MR, Fiorenza NG, Ferreira J, Rubin MA, et al. The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement. Behav Brain Res. 2008;187:200–204.
Royes LF, Fighera MR, Furian AF, Oliveira MS, Fiorenza NG, Ferreira J, et al. Neuromodulatory effect of creatine on extracellular action potentials in rat hippocampus: role of NMDA receptors. Neurochem Int. 2008;53:33–37.
Andres RH, Ducraya AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system. Brain Res Bull. 2008;76:329–43.
Genius J, Geiger J, Bender A, Moller H-J, Klopstock T, Rujescu D. Creatine protects against excitotoxicity in an in vitro model of neurodegeneration. PLoS ONE. 2012; 7: epub ahead of print 8 February 2012; https://doi.org/10.1371/journal.pone.0030554.
Zahr NM, Mayer D, Rohlfing T, Sullivan EV, Pfefferbaum A. Imaging neuroinflammation? A perspective from MR spectroscopy. Brain Pathol. 2014;24:654–64.
Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001;265:54–84.
Acosta-Martínez M. Shaping microglial phenotypes through estrogen receptors: relevance to sex-specific neuroinflammatory responses to brain injury and disease. J Pharm Exp Ther. 2020;375:223–36.
Azcoitia I, Barreto GE, Garcia-Segura LM. Molecular mechanisms and cellular events involved in the neuroprotective actions of estradiol. Analysis of sex differences. Front Neuroendocrinol. 2019; 55:epub ahead of print 9 September 2019; https://doi.org/10.1016/j.yfrne.2019.100787. Epub 2019 Sep 9.
Giraud SN, Caron CM, Pham-Dinh D, Kitabgi P, Nicot AB. Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. PNAS USA. 2010;107:8416–21.
Spence RD, Wisdom AJ, Cao Y, Hill HM, Mongerson CR, Stapornkul B, et al. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons. J Neurosci. 2013;33:10924–33.
De Nicola AF, Garay LI, Meyer M, Guennoun R, Sitruk‐Ware R, Schumacher M et al. Neurosteroidogenesis and progesterone anti‐inflammatory/neuroprotective effects. J Neuroendocrinol. 2018; 30: epub ahead of print e12502. https://doi.org/10.1111/jne.12502.
Pettus EH, Wright DW, Stein DG, Hoffman SW. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 2005;1049:112–119.
Janes AC, Pizzagalli DA, Richardt S, Frederick BD, Chuzi S, Pachas G, et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry. 2010;67:722–729.
Thoma R, Mullins P, Ruhl D, Monnig M, Yeo RA, Caprihan A, et al. Perturbation of the glutamate–glutamine system in alcohol dependence and remission. Neuropsychopharmacology. 2011;36:1359–65.
Wiers CE, Cunningham SI. Tomasi DG, Ernst T, Chang L, Shokri-Kojori E et al. Elevated thalamic glutamate levels and reduced water diffusivity in alcohol use disorder: association with impulsivity. Psychiatry Res: Neuroimaging. 2020; 305: epub ahead of print 30 November; https://doi.org/10.1016/j.pscychresns.2020.111185.
Liu X-L, Li L, Li J-N, Tang J-H, Rong J-H, Liu B, et al. Quantifying absolute glutamate concentrations in nucleus accumbens of prescription opioid addicts by using 1H MRS. Brain Behav. 2017;7:e00769.
Colizzi M, Weltens N, McGuire P, Lythgoe D, Williams S, Van Oudenhove L, et al. Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Mol Psychiatry. 2020;25:3231–40.
Kanaan AS, Gerasch S, García-García I, Lampe L, Pampel A, Anwander A, et al. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome. Brain. 2017;140:218–34.
Rowland LM, Kontson K, West J, Edden RA, Zhu H, Wijtenburg SA, et al. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull. 2013;39:1096–104.
Korenic SA, Klingaman EA, Wickwire EM, Gaston FE, Chen H, Wijtenburg SA, et al. Sleep quality is related to brain glutamate and symptom severity in schizophrenia. J Psychiatr Res. 2020;120:14–20.
Gao M, Aveyard P, Lindson N, Hartmann-Boyce J, Watkinson P, Young D, et al. Association between smoking, e-cigarette use and severe COVID-19: a cohort study. Int J Epidemiol. 2022;51:1062–72.
Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413.